These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 16899623

  • 21. Abrogation of VEGF expression in human head and neck squamous cell carcinoma decreases angiogenic activity in vitro and in vivo.
    Riedel F, Götte K, Li M, Hörmann K, Grandis JR.
    Int J Oncol; 2003 Sep; 23(3):577-83. PubMed ID: 12888890
    [Abstract] [Full Text] [Related]

  • 22. Roles of nitric oxide synthase inhibition and vascular endothelial growth factor receptor-2 inhibition on vascular morphology and function in an in vivo model of pancreatic cancer.
    Camp ER, Yang A, Liu W, Fan F, Somcio R, Hicklin DJ, Ellis LM.
    Clin Cancer Res; 2006 Apr 15; 12(8):2628-33. PubMed ID: 16638876
    [Abstract] [Full Text] [Related]

  • 23. Vector-based RNAi approach to isoform-specific downregulation of vascular endothelial growth factor (VEGF)165 expression in human leukemia cells.
    Shen HL, Xu W, Wu ZY, Zhou LL, Qin RJ, Tang HR.
    Leuk Res; 2007 Apr 15; 31(4):515-21. PubMed ID: 17034851
    [Abstract] [Full Text] [Related]

  • 24. Relationship between vessel density and expression of vascular endothelial growth factor and basic fibroblast growth factor in small cell lung cancer in vivo and in vitro.
    Lund EL, Thorsen C, Pedersen MW, Junker N, Kristjansen PE.
    Clin Cancer Res; 2000 Nov 15; 6(11):4287-91. PubMed ID: 11106245
    [Abstract] [Full Text] [Related]

  • 25. RUNX3 inhibits the expression of vascular endothelial growth factor and reduces the angiogenesis, growth, and metastasis of human gastric cancer.
    Peng Z, Wei D, Wang L, Tang H, Zhang J, Le X, Jia Z, Li Q, Xie K.
    Clin Cancer Res; 2006 Nov 01; 12(21):6386-94. PubMed ID: 17085650
    [Abstract] [Full Text] [Related]

  • 26. siRNA targeting VEGF inhibits hepatocellular carcinoma growth and tumor angiogenesis in vivo.
    Raskopf E, Vogt A, Sauerbruch T, Schmitz V.
    J Hepatol; 2008 Dec 01; 49(6):977-84. PubMed ID: 18845354
    [Abstract] [Full Text] [Related]

  • 27. Regulation of the pro-angiogenic microenvironment by carboxyamido-triazole.
    Oliver VK, Patton AM, Desai S, Lorang D, Libutti SK, Kohn EC.
    J Cell Physiol; 2003 Oct 01; 197(1):139-48. PubMed ID: 12942550
    [Abstract] [Full Text] [Related]

  • 28. Signal transducer and activator of transcription 1 activation in endothelial cells is a negative regulator of angiogenesis.
    Battle TE, Lynch RA, Frank DA.
    Cancer Res; 2006 Apr 01; 66(7):3649-57. PubMed ID: 16585190
    [Abstract] [Full Text] [Related]

  • 29. VEGF antisense therapy inhibits tumor growth and improves survival in experimental pancreatic cancer.
    Hotz HG, Hines OJ, Masood R, Hotz B, Foitzik T, Buhr HJ, Gill PS, Reber HA.
    Surgery; 2005 Feb 01; 137(2):192-9. PubMed ID: 15674201
    [Abstract] [Full Text] [Related]

  • 30. mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor.
    Lane HA, Wood JM, McSheehy PM, Allegrini PR, Boulay A, Brueggen J, Littlewood-Evans A, Maira SM, Martiny-Baron G, Schnell CR, Sini P, O'Reilly T.
    Clin Cancer Res; 2009 Mar 01; 15(5):1612-22. PubMed ID: 19223496
    [Abstract] [Full Text] [Related]

  • 31. VEGF-mediated angiogenesis of human pheochromocytomas is associated to malignancy and inhibited by anti-VEGF antibodies in experimental tumors.
    Zielke A, Middeke M, Hoffmann S, Colombo-Benkmann M, Barth P, Hassan I, Wunderlich A, Hofbauer LC, Duh QY.
    Surgery; 2002 Dec 01; 132(6):1056-63; discussion 1063. PubMed ID: 12490855
    [Abstract] [Full Text] [Related]

  • 32. Broad antitumor activity in breast cancer xenografts by motesanib, a highly selective, oral inhibitor of vascular endothelial growth factor, platelet-derived growth factor, and Kit receptors.
    Coxon A, Bush T, Saffran D, Kaufman S, Belmontes B, Rex K, Hughes P, Caenepeel S, Rottman JB, Tasker A, Patel V, Kendall R, Radinsky R, Polverino A.
    Clin Cancer Res; 2009 Jan 01; 15(1):110-8. PubMed ID: 19118038
    [Abstract] [Full Text] [Related]

  • 33. Suppression of growth of pancreatic cancer cell and expression of vascular endothelial growth factor by gene silencing with RNA interference.
    Wang J, Shi YQ, Yi J, Ye S, Wang LM, Xu YP, He M, Kong XM.
    J Dig Dis; 2008 Nov 01; 9(4):228-37. PubMed ID: 18959596
    [Abstract] [Full Text] [Related]

  • 34. Semaphorin SEMA3F affects multiple signaling pathways in lung cancer cells.
    Potiron VA, Sharma G, Nasarre P, Clarhaut JA, Augustin HG, Gemmill RM, Roche J, Drabkin HA.
    Cancer Res; 2007 Sep 15; 67(18):8708-15. PubMed ID: 17875711
    [Abstract] [Full Text] [Related]

  • 35. Increased VEGF levels induced by anti-VEGF treatment are independent of tumor burden in colorectal carcinomas in mice.
    Schmitz V, Vilanueva H, Raskopf E, Hilbert T, Barajas M, Dzienisowicz C, Gorschlüter M, Strehl J, Rabe C, Sauerbruch T, Prieto J, Caselmann WH, Qian C.
    Gene Ther; 2006 Aug 15; 13(16):1198-205. PubMed ID: 16617302
    [Abstract] [Full Text] [Related]

  • 36. Antisense oligodeoxynucleotide inhibits vascular endothelial growth factor in human glioma cells.
    Zheng SX, Zhou LJ, Zhu XZ, Jin YX.
    Acta Pharmacol Sin; 2000 Mar 15; 21(3):211-4. PubMed ID: 11324417
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Antiangiogenic therapy of head and neck squamous cell carcinoma by vascular endothelial growth factor antisense therapy.
    Riedel F, Götte K, Hörmann K, Grandis JR.
    Adv Otorhinolaryngol; 2005 Mar 15; 62():103-20. PubMed ID: 15608422
    [Abstract] [Full Text] [Related]

  • 39. [Effect of vascular endothelial growth factor antisense oligodeoxynucleotides on angiogenesis in lymphoma of nude mice].
    Tong YJ, Zhang M, Zou P, Guo R, Yuan YH.
    Ai Zheng; 2005 Jan 15; 24(1):62-6. PubMed ID: 15642202
    [Abstract] [Full Text] [Related]

  • 40. Vector-based RNA interference against vascular endothelial growth factor-C inhibits tumor lymphangiogenesis and growth of colorectal cancer in vivo in mice.
    He XW, Yu X, Liu T, Yu SY, Chen DJ.
    Chin Med J (Engl); 2008 Mar 05; 121(5):439-44. PubMed ID: 18364118
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.